JAZLEN SAMBOY: Open Payments
NPI 1093137655 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 24 payments from 12 companies in 2025. Trend: 2023 $590 · 2024 $849 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $123 |
| Astellas Pharma US Inc | 2 | $70 |
| Lilly USA, LLC | 3 | $63 |
| Madrigal Pharmaceuticals | 3 | $58 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| ABBVIE INC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| PFIZER INC. | 1 | $30 |
| Novo Nordisk Inc | 1 | $25 |
Products named: OTEZLA, Veozah, MOUNJARO, REZDIFFRA, TRELEGY ELLIPTA, QULIPTA, FARXIGA, Symbravo.
Industry payments across NY — which companies pay providers there.
